Therapeutic drug monitoring shows promise for infliximab maintenance: study
Results from the NOR-DRUM B study suggest a proactive approach improves chances of achieving sustained disease control.
Tag: Rheumatology
Tapering or stopping therapy ‘high risk for flares’ in lupus
The findings highlight the complexity of managing these patients and the influence of demographic as well as clinical factors on outcomes, research…
Rheumatologists ‘face rituximab dilemma’ with endemic COVID-19
Yet another study shows that, alone among immunosuppressants, the monoclonal antibody is linked to increased mortality among the infected.
Could ultrasound replace temporal artery biopsy for giant cell arteritis?
A blinded study in patients with the condition shows high diagnostic accuracy, researchers say.
Biologics may stave off arthritis in people with psoriasis: study
Patients with risk factors for psoriatic arthritis might benefit from starting the agents early, the researchers say.
Infections, low IgG ‘common’ in children on rituximab
Boston hospital study suggests corticosteroids compound the risk, researchers say.
Can you crack this cutaneous clue?
A sprinkling of hyperpigmentation and a pinch of hypopigmentation.
Benefits of statins ‘outweigh potential harms’, finds major review
Risk of muscle disorders is low and should not deter use for CVD prevention, UK researchers find.
What’s causing this orange-peel skin on the elbows?
Jason, a 45-year-old plumber, attends regarding his elbows. He reports that a few weeks ago they became painful, tender, swollen and red.
Pfizer vax linked to rheumatic disease flares
One in six patients with rheumatic disease experience flares following COVID-19 vaccination: study
